At a glance
- A US private placement is a note rated to investment grade standards at origination and placed with a limited group of institutional lenders rather than sold publicly.
- For an allocator reviewing a private credit sleeve, two structural facts matter more than the fund's label: the rating standard at origination and the lender panel the manager can reach.
- Life insurers held $849 billion of private placements at the end of 2024, more than double the $386 billion of a decade earlier.
US investment grade private corporate credit issuance reached a record $211.1 billion in 2025, up 33% on 2024, and volume through June 2026 ran 69% ahead of the same period a year earlier, according to an article published Oct. 14 by Insurance AUM Journal.
A US private placement is a note rated to investment grade standards at origination and placed with a limited group of institutional lenders rather than sold publicly. The Journal describes the paper as originated, underwritten and rated to investment grade standards as a Reg D bond or note, arranged either directly with a borrower or through an agent bank that brings an issuer to a panel of private lenders.
For an allocator reviewing a private credit sleeve, two structural facts matter more than the fund's label: the rating standard at origination and the lender panel the manager can reach. The Journal says investment grade placements sit alongside, and are often confused with, the broader "private credit" label, which in recent years has come to mean direct lending to mainly below-investment grade borrowers. A sleeve built around investment grade placements is a different exposure from one built on below-investment grade loans, whichever name is on the vehicle.
Life insurers are the market's dominant buyers
Life insurers held $849 billion of private placements at the end of 2024, more than double the $386 billion of a decade earlier. The Journal calls them the market's dominant buyers and says the asset class rose from 10% to 14% of general account assets over that period. Those holdings figures are dated to the end of 2024, while the issuance numbers run to June 2026.
Growth is not simply a yield calculation, per the Journal. It describes a deliberate reallocation by long-duration institutional investors toward an asset class that also offers negotiated covenants, tailored structuring and, for insurers, capital treatment equivalent to a comparable public bond. The capital-treatment point is specific to insurance balance sheets, which suggests covenants and structuring carry more of the case for other buyers.
Corporate placements are one of three sub-platforms
Used broadly, the term spans corporate placements, infrastructure debt and privately placed asset-backed securities, each treated as a distinct sub-platform. The Journal focuses on corporate placements, described as the market's original and largest segment. Practitioners increasingly add "IG" to the front of their own activity to draw the line, and the market predates the below-investment grade direct lending market by decades.
Covenants are negotiated with the borrower and structures are tailored, and the paper goes to a limited panel of lenders rather than the public bond market, which suggests panel access rather than volume is the practical constraint on what a vehicle can hold. The Journal's issuance data runs through June 2026; full-year volume is the next checkpoint.
Reported by the Private Credit & BDCs desk from Insurance AUM Journal. Published . Updated Oct 25, 2026 · 1:33 p.m. ET. Corrections